Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear protein 2, transcriptional regulator (NUPR2), also called nuclear protein 1-like (NUPR1L) or P8, is a small nuclear transcription factor involved in the negative regulation of cell proliferation and transcription[3]. It functions as a transcriptional repressor with inhibitory effects at the NUPR1 promoter in a p53-dependent manner, leading to G1 cell cycle arrest and reduced cell viability[3][6]. NUPR2 mutually antagonizes NUPR1, a protumoral factor, and is itself regulated by p53 responsive elements—its expression rises with stress conditions such as serum starvation and is reduced by NUPR1 activity[6]. Unlike NUPR1, which is pro-oncogenic, NUPR2 exhibits tumor-suppressive properties in some contexts (e.g., colorectal cancer cells)[6]. NUPR2 binds known NUPR1 partners (including RING1B) and can form complexes with NUPR1. NUPR2 is associated with Dyskeratosis Congenita and may play roles in stress regulation beyond cancer, but direct evidence for targeting or therapeutic intervention is lacking[3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear protein 2, transcriptional regulator (NUPR2).